Federal Register of Legislation - Australian Government

Primary content

PB 111 of 2010 Determinations/Health as made
This Determination amends the National Health Act 1953 - Determination under paragraph 98C(1)(b) - conditions (No. PB 119 of 2008) to provide for changes to the conditions subject to which payment will be made by the Commonwealth in respect of the supply of pharmaceutical benefits by approved medical practitioners.
Administered by: Health
Registered 30 Nov 2010
Tabling HistoryDate
Tabled HR08-Feb-2011
Tabled Senate08-Feb-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014



Instrument number PB 111 of 2010

Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953

I, DAVID LEARMONTH, Deputy Secretary, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.


Dated 29 November 2010






Deputy Secretary

Department of Health and Ageing

Amendment determination — conditions

1              Commencement                                                        

                This instrument commences on 1 December 2010.

2              Amendment of PB 119 of 2008

                Schedule 1 amends PB 119 of 2008.

Schedule 1            Amendments


[1]      Schedule 4, after items dealing with Dabigatran etexilate

insert in the columns in the order indicated:


Powder for injection 120 mg (as acetate) with solvent, syringe and needles, 2

[2]      Schedule 4, item dealing with Macrogol 3350

omit from the column headed “Form (strength, type, size, etc.)”:


Sachets containing powder for oral solution 6.563 g with electrolytes, 30











































All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 

See http://www.frli.gov.au.